AES Semigas


11 September 2023

BluGlass appoints full-time CFO to support growth

BluGlass Ltd of Silverwater, Australia — which develops and manufactures gallium nitride (GaN) blue laser diodes based on its proprietary low-temperature, low-hydrogen remote-plasma chemical vapor deposition (RPCVD) technology — has appointed Samuel Samhan as chief financial officer on a full-time basis, effective immediately.

Samhan has more than 20 years of experience in financial leadership and commercial operations. He was previously chief operating & financial officer at global health platform Digital Wellness. Other roles include head of commercial and business transformation at Vitality Works – Sanitarium Workplace Health and Wellness, and commercial manager at Evolution Healthcare Group.

Samhan replaces part-time CFO Rob Ambrogio, who resigned from the position to pursue personal projects. To ensure a smooth transition, Ambrogio will remain with the firm until 29 September.

“Sam brings hands-on experience transforming financial and commercial operations to significantly increase profitability,” says CEO Jim Haden. “Given our commercialization progress, we felt the time was right for a full-time CFO, and Sam’s domestic and international expertise in business model innovation and cost-effective strategies will be invaluable as we continue to scale our laser production capability to meet unmet market needs and grow revenues,” he adds.

“I’d like to thank Rob for his significant contribution to the company over the past year, supporting the broader leadership team as we expanded our operations across the US and Australia,” Haden continues.

“In addition to scaling customer orders and revenues, I see further growth opportunities for the business as it continues to expand its product portfolio,” comments Samhan.

Samhan holds a Bachelor of Business (Accounting), Master of Business Administration, and is a graduate of the Australian Institute of Company Directors.

Tags: BluGlass RPCVD